Abstract
The discovery of a receptor for renin and for its inactive precursor prorenin, and the introduction of renin inhibitors in therapeutic, has renewed the interest for the physiology of the renin-angiotensin system (RAS) and has brought prorenin back in the spotlight. The receptor known as (P)RR for (pro)renin receptor binds both renin and prorenin, and binding triggers intracellular signaling involving the MAP kinases ERK1/2 and p38. The MAP kinases activation in turn upregulates the expression of profibrotic genes, potentially leading to fibrosis, growth, and remodeling. Simultaneously, binding of renin to (P)RR increases its angiotensin I generating activity, whereas binding of prorenin induces the inactive prorenin to become enzymatically active. These biochemical characteristics of (pro)renin binding to (P)RR allow to distinguish two aspects for the new (pro)renin/(P)RR system, an angiotensin-independent function related to the intracellular signaling and its downstream effects, and an angiotensin-dependent aspect related to the increased generation of angiotensin I on the cell surface. Ongoing experimental studies should now determine which of the two aspects is the most important in pathological situations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- (pro)renin::
-
designate renin and prorenin
- AOG::
-
angiotensinogen
- Ang I and Ang II::
-
angiotensin I and angiotensin II
- ACE::
-
angiotensin converting enzyme
- HRP::
-
handle region peptide
- (P)RRB::
-
(pro)renin receptor blocker
References
Amsterdam A, Nissen RM, Sun Z, et al. Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci USA. 2004;101:12792–12797.
Batenburg WW, Krop M, Garrelds IM, et al. Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hypertens. 2007;25:2441–2453.
Burcklé C, Bader M. Prorenin and its ancient receptor. Hypertension. 2006;48:549–551.
Burcklé CA, Danser AHJ, Müller DN, et al. Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension. 2006;47:552–556.
Contrepas A, Praizovic N, Duong Van Huyen JP, et al. Expression of (pro)renin receptor in mouse embryonic and newborn kidney and proliferative effect of soluble (P)RR on mesangial cells. Hypertension. 2007 50:e145 (Abstract).
Danser AHJ, Deinum J. Renin, prorenin and the putative (pro)renin receptor. Hypertension. 2005;46:1069–1076.
Danser AHJ, Derkx FHM, Schalekamp MADH, et al. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens. 1998;16:853–862.
Feldt S, Batenburg WW, Mazak I, et al. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension. 2008a;51:682–688.
Feldt S, Maschke U, Dechend R, et al. The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol. 2008b;19(4):743–748.
Huang Y, Border WA, Noble NA. Functional renin receptors in renal mesangial cells. Curr Hypertens Rep. 2007a;9:133–139.
Huang Y, Noble NA, Zhang J, et al. Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int. 2007b;72:45–52.
Huang Y, Wongamorntham S, Kasting J, et al. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 2006;69:105–113.
Ichihara A, Hayashi M, Kaneshiro Y, et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle"region for nonproteolytic activation of prorenin. J Clin Invest. 2004;114:1128–1135.
Ichihara A, Kaneshiro Y, Takemitsu T, et al. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension. 2006a;47:894–900.
Ichihara A, Suzuki F, Nakagawa T, et al. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol. 2006b;17:1950–1961.
Kaneshiro Y, Ichihara A, Sakoda M, et al. Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol. 2007;18:1789–1795.
Kaneshiro Y, Ichihara A, Takemitsu T, et al. Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int. 2006;70:641–646.
Krebs C, Hamming I, Sadaghiani S, et al. Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats. Kidney Int. 2007;72:725–730.
Krop M, Danser AH (2008). Circulating versus tissue renin-angiotensin system: on the origin of (pro)renin. Curr Rep. Hypertens 2008;10:112–118.
Lenz T, Sealey JE, Maack T, et al. Half-life, hemodynamic, renal, and hormonal effects of prorenin in cynomolgus monkeys. Am J Physiol. 1991;260:R804–810.
L’Huillier N, Sharp MGF, Dunbar DR, et al. On the relationship between the renin receptor and the vacuolar proton ATPase membrane sector associated protein (M8-9). In: Frolich ED, Re RN, eds. The Local Cardiac Renin Angiotensin-Aldosterone System. New York: Springer; 2005:17–34, Chapter 3.
Ludwig J, Kerscher S, Brandt U, et al. Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J Biol Chem. 1998;273:10939–10947.
Luetscher JA, Kraemer FB, Wilson DM, et al. Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N Engl J Med. 1985;312:1412–1417.
Maru I, Ohta Y, Murata K, et al. Molecular cloning and identification of N-acyl-D-glucosamine 2-epimerase from porcine kidney as a renin-binding protein. J Biol Chem. 1996;271:16294–16299.
Methot D, Silversides DW, Reudelhuber TL. In vivo enzymatic assay reveals catalytic activity of the human renin precursor in tissues. Circ Res. 1999;84:1067–1072.
Müller DN, Klanke B, Feldt S, et al. (Pro)renin receptor peptide inhibitor “handle-region” peptide does not affect hypertensive nephrosclerosis in Goldblatt rats. Hypertension. 2008;51:676–681.
Nabi AH, Kageshima A, Uddin MN, et al. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med. 2006;18:483–488.
Nguyen G, Danser AH. Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents. Exp Physiol. 2008;93:557–563.
Nguyen G, Delarue F, Burckle C, et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109:1417–1427.
Nishi T, Forgac M. The vacuolar (H+)-ATPases – nature's most versatile proton pumps. Nat Rev Mol Cell Biol. 2002;3:94–103.
Peters B, Grisk O, Becher B, et al. Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis. J Hypertens. 2008;26:102–109.
Prescott G, Silversides DW, Reudelhuber TL. Tissue activity of circulating prorenin. Am J Hypertens. 2002;15:280–285.
Sakoda M, Ichihara A, Kaneshiro Y, et al. (Pro)renin receptor-mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells. Hypertens Res. 2007;30:1139–1146.
Saris JJ, Derkx FHM, de Bruin RJA, et al. High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin. Am J Physiol. 2001a;280:H1706–H1715.
Saris JJ, van den Eijnden MMED, Lamers JMJ, et al. Prorenin-induced myocyte proliferation: no role for intracellular angiotensin II. Hypertension. 2002;39:573–577.
Saris JJ, 't Hoen PAC, Garrelds IM, et al. Prorenin induces intracellular signalling in cardiomyocytes independently of angiotensin II. Hypertension. 2006;48:564–571.
Satofuka S, Ichihara A, Nagai N, et al. Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci. 2006;47:2686–2692.
Schefe JH, Menk M, Reinemund J, et al. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res. 2006;99:1355–1366.
Schefe JH, Neumann C, Goebel M, et al. Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren. J Hypertens. 2008;26:1787–1794.
Schmitz C, Gotthardt M, Hinderlich S, et al. Normal blood pressure and plasma renin activity in mice lacking the renin-binding protein, a cellular renin inhibitor. J Biol Chem. 2000;275:15357–15362.
Siragy HM, Huang J. Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity. Exp Physiol. 2008;93(5):709–714.
Stankovic AR, Fisher NDL, Hollenberg NK. Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes. J Am Soc Nephrol. 2006;17:3293–3299.
Suzuki F, Hayakawa M, Nakagawa T, et al. Human prorenin has “gate and handle” regions for its non-proteolytic activation. J Biol Chem. 2003;278:22217–22222.
Takahashi H, Ichihara A, Kaneshiro Y, et al. Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade. J Am Soc Nephrol. 2007;18:2054–2061.
Tigerstedt R, Bergman PG. Niere und Kreislauf. Scand Arch Physiol. 1898;8:223–271.
van den Eijnden MMED, Saris JJ, et al. Prorenin accumulation and activation in human endothelial cells. Importance of mannose 6-phosphate receptors. Arterioscler Thromb Vasc Biol. 2001;21:911–916.
van Kesteren CAM, Danser AHJ, Derkx FHM, et al. Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension. 1997;30:1389–1396.
Véniant M, Ménard J, Bruneval P, et al. Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest. 1996;98:1966–1970.
Wilson DM, Luetscher JA. Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med. 1990;323(16):1101–1106.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this paper
Cite this paper
Nguyen, G., Contrepas, A. (2009). Renin, Prorenin, and the (Pro)renin Receptor. In: Frohlich, E., Re, R. (eds) The Local Cardiac Renin-Angiotensin Aldosterone System. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-0528-4_3
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0528-4_3
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-0527-7
Online ISBN: 978-1-4419-0528-4
eBook Packages: MedicineMedicine (R0)